epilepsy

human brain abstract art
Biotech

Angelini signs $550M-plus neuro pact with South Korean biotech

Angelini Pharma has worked out a $550 million-plus biobucks deal to get its hands on a Korean biotech’s preclinical neuro asset.
Gabrielle Masson Sep 22, 2025 1:47pm
rocket ship blast off fire away take off

Rapport's seizure drug hits in phase 2, sending stock soaring

Sep 8, 2025 8:25am
jazz musicians band music saxophone

Jazz pays Saniona $42.5M to add prospect to epilepsy ensemble

Aug 20, 2025 9:13am
scissor cutting rope

J&J calls time on Addex partnership a year after epilepsy fail

Apr 17, 2025 7:05am
Person lacing up running shoe

Atalanta’s RNA epilepsy asset suppresses seizures in mice

Apr 10, 2025 5:30am
dollar sign with colored arrows in a maze

Cell therapy biotech bags $102M to fund phase 3 epilepsy plans

Apr 3, 2025 1:22pm